Recent Featured News
Market Pulse Navigator is dedicated to profiling emerging growth opportunities to the investment community, especially those interested in small cap investing. Some of these dynamic and innovative publicly traded companies, many of which trade on the OTC markets, might be overlooked by Wall Street radar. Market Pulse Navigator provides an outlet for these companies, and has become a recognized voice in the small-cap community.
Market Pulse Navigator provides informative articles on developing companies who are breaking ground -- literally and figuratively -- in the business world. New and recently re-focused companies are profiled, covering current activities and future goals.
Investing always involves some level of risk, so before you invest in any security, please research it thoroughly. Through this website we provide links to free information so you can educate yourself on our featured small cap stock issues, and make informed decisions to help meet your personal finance goals.
Market Pulse Navigator also maintains a free financial online newsletter. This will provide you with the materials you need to make informed decisions about emerging growth companies across the globe. Don't miss this opportunity to receive your free newsletter profiling small- and micro-cap companies. Simply enter your e-mail address in the Join Our List section above, and submit it to receive this great free resource in your e-mailbox each month.
Current Profile
Mediaone International, Inc. (OTCBB: MZEI) is a research and development company engaged in developing AsepticSure™ System, a novel ozone-based technology. AsepticSure™ is a portable decontamination and sterilization system for hospitals, government buildings, sports training facilities, schools and other critical infrastructure that might currently require, or need to be prepared for countermeasures capability from contamination by infectious biological agents. It is anticipated that AsepticSure™ will be extremely cost effective and adaptable to virtually any situation anywhere and have a global reach. A government variant is being developed for bio-terrorism counter measures.
The company believes that Medizone's unique ozone generating technologies could play a vital role in addressing what public health officials and surgeons worldwide are beginning to recognize as "the silent epidemic", a reference to MRSA (methicillin-resistant staphylococcus aureus) infection.
Medizone’s CEO Edwin Marshall added, “Following the impressive results recently announced for MRSA, we immediately began to assess the capability of AsepticSure™ using the same updated technology with the spore forming bacteria C. difficile, which is ubiquitous within hospitals and chronic care centers. Following those results we then worked with Bacillus subtilis, which represents the infamous and highly lethal terrorist agent, Anthrax. In both cases, these two pathogens remain very resistant to standard decontamination procedures and hence, seeing our technology virtually annihilate these two difficult spore formers has lead Medizone to a parallel track of development with its AsepticSure™ technology which we are convinced will open up the possibility for commercialization in both arenas."
Medizone believes that a field hardened variant of the AsepticSure™ hospital unit currently being readied for scale up testing will have wide bio defense applications internationally as it will be easily deployable in response to virtually any terrorist assault, extremely effective against a broad range of lethal pathogens, easy to manage and maintain and most importantly, it has the potential to save lives. Medizone International, Inc. is poised to become a significant player in the healthcare industry!
More Company Profiles
Current Profile | Profiles | Resources | Subscribe | Contact Us | Disclaimer
Market Pulse Navigator All Rights Reserved.
© Copyright 2012
Current Profile
